David Carroll - Dec 20, 2022 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role
SVP, Chief Financial Officer
Signature
/s/ Todd D.C. Anderman, as Attorney-in-Fact for David Carroll
Stock symbol
ISEE
Transactions as of
Dec 20, 2022
Transactions value $
$0
Form type
4
Date filed
12/22/2022, 05:55 PM
Previous filing
Dec 20, 2022
Next filing
Jan 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Stock Option (right to buy) Award $0 +75K $0.00 75K Dec 20, 2022 Common Stock 75K $22.57 Direct F1
transaction ISEE Restricted Stock Units Award $0 +37.5K $0.00 37.5K Dec 20, 2022 Common Stock 37.5K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares, in approximately equal monthly installments through the fourth anniversary of the grant date.
F2 Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
F3 Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award in annual installments (on January 2, 2024, January 2, 2025, January 2, 2026 and January 2, 2027).